Borthwick Kathleen bought PASG
February 10, 2024 · Form 4 insider transaction
Borthwick Kathleen bought 4,000 shares of Passage Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
N/A
Total value
N/A
InsiderBorthwick Kathleen
RoleOfficer
CompanyPassage Bio, Inc. (PASG)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 10, 2024
Filing dateFebruary 13, 2024
Shares owned after29,936
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.